ERVW-1 and preeclampsia: Several research groups detected that conditions associated with placental pathology such as preeclampsia lead to differences in total EV quantities in maternal plasma and that the fraction of syncytiotrophoblast-specific EVs (containing syncytin-1) is significantly changed [56–58].